Dr. Mazer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 walters str
Suite 510
Albuquerque, NM 87106Phone+1 505-727-3170
Education & Training
- Brown UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2006 - 2009
- Brown UniversityResidency, Internal Medicine, 2002 - 2006
- Tufts University School of MedicineClass of 2002
Certifications & Licensure
- NM State Medical License 2014 - 2026
- RI State Medical License 2005 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 8 citationsC-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade.Brian Casserly, Jeffrey Mazer, Alexander Vang, Elizabeth O. Harrington, James R. Klinger
Life Sciences. 2011-09-26 - 41 citationsActivation of endothelial BKCa channels causes pulmonary vasodilation.Alexander Vang, Jeffrey Mazer, Brian Casserly, Gaurav Choudhary
Vascular Pharmacology. 2010-09-01 - 11 citationsArterial Catheter Use in the ICU: A National Survey of Antiseptic Technique and Perceived Infectious Risk.Gerardo Carino, Daithi S. Heffernan, Stephanie N. Lueckel, Jeffrey Mazer, Dorothy Skierkowski
Critical Care Medicine. 2015-11-01
Press Mentions
- Lovelace Administers Pfizer Vaccines to Frontline Workers for the First TimeDecember 16th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: